UTCOMES following surgery for medically intractable epilepsy have gradually improved over the second half of the twentieth century. In most modern series the percentage of patients rendered free from seizure after medial temporal resections generally approaches 70 to 80%, with an additional 15 to 25% of patients finding worthwhile improvement. 12, 17, 55 Similar outcomes are reported for extratemporal lesional epilepsy.
* A = no seizures, auras only; ATL = anterior temporal lobectomy and radical amygdalohippocampectomy; B = marked decrease in seizures; C = moderate decrease in seizures; CC = corpus callosotomy; CM = cavernous malformation; D = minimal or no decrease in seizures; DNET = dysembryoplastic neuroepithelial tumor; DP = dual pathology; Dx = diagnosis; F/U = follow up; HA = hippocampal atrophy; HHE = hemiconvulsions, hemiplegia, epilepsy; MRI = MR imaging; MST = multiple subpial transections; neuropsych = neuropsychological findings; ODG = oligodendroglioma; Rasmussen = Rasmussen encephalitis; TB = tuberculosis; TP = triple pathology; -= not applicable.
† Patient refused further workup.
We can infer from these data that a careful initial surgical selection and an aggressive treatment strategy will successfully control seizures in these patients whose epilepsy can be controlled by surgery. Treatment failures often arise from the emergence of secondary epileptogenesis, disease progression, or limited resections to preserve functional tissue. This series also contains a number of patients with severe intractable epilepsy who were selected for surgery that is intentionally palliative, the goal of which is not seizure cure but manageability. These patients often require multiple interventions to achieve adequate seizure control and may become an increasing percentage of those undergoing epilepsy reoperations as new neuroaugmentation procedures are introduced into common practice.
Clinical Material and Methods

Patient Population
Patients included in this study fulfilled the following criteria. 1) They underwent two or more surgical interventions performed at Yale-New Haven Hospital for medically intractable epilepsy (lesional or nonlesional). First surgeries were performed between January 1988 and August 1998 and second surgeries between January 1990 and March 2000. 2) Initial evaluations included MR imaging. 3) Complete evaluations were performed in accordance with standard procedures of the YEC. 4) Patients participated in at least 1-year follow-up review after the second surgery. Presurgical evaluation is detailed elsewhere. 62 In short, the workup consisted of four parts. Phase 1 was composed of history gathering, neurological examination, video EEG monitoring of the scalp for a minimum of three ictal events, neuroimaging (MR imaging), and neuropsychological testing. Phase 2 consisted of amytal testing (unless already performed before the first operation) and, when available, interictal positron emission tomography scanning, ictal and interictal singlephoton emission computerized tomography scanning, and MR spectroscopy. Phase 3 consisted of intracranial monitoring of at least three ictal events. Not all patients underwent the third phase, however, because the YEC policy stipulates a low threshold for intracranial monitoring. Patients in whom discordant or suspicious findings arose during the first and second parts of the experiment and patients with developmental abnormalities were generally selected for invasive study. Patients with residual lesions (not developmental abnormalities) and concordant EEG tracings were not required to undergo invasive monitoring unless the lesion was adjacent to previously unmapped functional cortex. Phase 4 of the experiment consisted of surgical intervention.
Surgical Strategies
Surgical strategies for the first and second operations were very similar. For patients with focal lesions and/or sites of ictal onset not involving functional cortex, surgical resection was designed as a curative procedure and the entire ictal onset zone was removed. In patients in whom the ictal onset zone overlapped functional cortex, two options existed: either subtotal resection and/or multiple subpial transections or stereotactic radiosurgery, or total resection involving sacrifice of function in a patient with either a preexisting neurological deficit or a high likelihood of cure with an acceptable loss of function. Patients with widespread anatomical abnormalities or multifocal onset zones and very frequent seizures were sometimes selected for surgical intervention as a palliative treatment. Possible strategies included corpus callosotomy, placement of a VNS, or subtotal resection. The latter intervention was used when either one particular type of seizure or a majority of seizures arose from a single location. Corpus callosotomy was used more frequently before VNS was introduced, but is now less commonly performed to avoid the neuropsychological consequences and the possible release of new, more intense seizures. 45, 56 
Data Analysis
Data collection with respect to seizure frequency consisted of a prospective accrual of outcomes in which the patients' seizure frequency was classified at each office visit into one of the four following categories: A, no seizures or auras only (including seizures precipitated by alterations in medications); B, marked decrease (75-99%) in seizure frequency; C, moderate decrease (50-75%) in seizure frequency; and D, minimal or no reduction (0-50%) in seizure frequency. Details of patients' histories and presurgical evaluations were amassed during a retrospective chart review of all office notes, hospital reports, and the record from the weekly epilepsy conference, in which clinical data are discussed by all members of the comprehensive epilepsy center.
Results
We identified 27 patients who fit the aforementioned criteria. Details of these patients' clinical histories and outcomes after reoperation are presented in Table 1 . The mean age of the patients at presentation was 22 Ϯ 12 years. In six patients (22%), the second surgery was intended as a palliative procedure (corpus callosotomy or placement of a VNS). The average follow-up period was 41.5 Ϯ 28.6 months (range 12-120 months). Of the 21 patients whose second surgeries were intended to be curative, only four (19%) became seizure free or experienced only auras following reoperation. Four of these 21 patients later underwent an additional palliative surgery (VNS placement) after a failed second operation. Five (83%) of the six patients who underwent a palliative second operation achieved more than a 50% reduction in seizure frequency. The details of each patient are outlined in Table 1 and a summary follows.
Mesial Temporal Sclerosis
In five patients the initial diagnosis was MTS, and these patients underwent a standard anterior medial temporal resection and total amygdalohippocampectomy. 54 Among these patients, the most common cause of surgical failure amenable to further surgery was dual pathological conditions (four of five patients), consisting of focal neocortical migration abnormalities identified in the histological analysis of the resected specimen (Table 2 ). In three of these four patients, reoperation consisted of extending the neo-cortical resection after a repeated Phase 3 evaluation confirmed the location of the ictal onsets. The remaining patient received placement of a VNS after refusing further evaluation. In all these patients, MR images failed to reveal any abnormalities in the neocortex. All patients underwent invasive monitoring before the first operation because preoperative information was discordant, including frequent secondary generalization, history of encephalitis, or nonlateralizing Phase 1 data. Despite neocortical coverage in three of these patients, neocortical onsets were not recorded during their first Phase 3 evaluations, although two patients had a minority of onsets arising from the contralateral temporal lobe. One of these patients was only monitored with depth electrodes, resulting in limited sampling. Hence, in most cases, an independent neocortical onset arose following removal of the medial temporal lobe focus. Two of these patients achieved a marked reduction in seizure frequency, and one experienced only a moderate reduction, indicating widespread neocortical disease in all patients. One of these patients underwent placement of a VNS for additional seizure control, which resulted in a moderate reduction in seizure frequency.
One patient had bitemporal onsets in which the majority of seizures arose from one side with concordant cognitive dysfunction. Recurrent seizures were documented from the contralateral hemisphere and the patient underwent placement of a VNS, resulting in a moderate reduction in seizure frequency.
Neocortical Lesions
Twenty patients suffered from neocortical disease visualized on MR images. Histological diagnoses are presented in Table 3 . Three patients with oligodendrogliomas had undergone subtotal resections to preserve functional cortex. In two of these patients the treatment failed due to tumor progression, but they ultimately achieved marked reductions in seizure frequency, in one case following further surgical debulking and in the second case following gamma knife surgery performed to treat the recurrent lesion in functional cortex. In the third patient the treatment failed without tumor progression, and reoperation was not successful at eliminating seizures. In this patient the Phase 3 evaluation had been limited by a sampling error due to extensive dural scarring, which impeded proper placement of the grid. Further neocortical resection failed to control the seizures, and the patient ultimately underwent placement of a VNS unit, resulting in a moderate reduction in seizure frequency.
Four other patients with neoplasms underwent complete resection of the epileptogenic lesion. In three of these patients the treatment failed due to disease progression, and the patients underwent further resection of the recurrent disease. Two patients were ultimately rendered seizure free, one of whom required sacrifice of the foot area, which had already been significantly weakened by tumor invasion. The patient whose seizures persisted had a marked reduction in seizure frequency following an incomplete resection that was limited by functional cortex. In the fourth patient a new neocortical focus emerged adjacent to a resected dysembryoplastic neuroepithelial tumor. Further cortical resection failed to control this patient's seizures, indicating widespread disease (dysplasia).
Two patients with vascular disease experienced treatment failure due to dual pathology, based on the emergence of a mesial focus. In both patients MR images revealed hippocampal atrophy, but invasive monitoring failed to demonstrate an epileptogenic hippocampus and neuropsychological testing indicated preserved memory bilaterally. Neither patient became free from seizure after an additional mesial resection of an epileptogenic hippocampus, which was identified by repeated invasive monitoring. One patient underwent an incomplete resection and in the other patient a developmental abnormality was identified in the histological specimen, indicating triple pathological conditions.
Two patients harbored gliotic neocortical lesions. In one patient treatment failed due to dual pathology in which mesial onsets emerged from an atrophic hippocampus. A Phase 3 evaluation had not been performed in this patient before the first surgery, and the patient became seizure free after a standard temporal lobectomy and amygdalohippocampectomy. The second patient's seizures arose from a cortical scar caused by an earlier intraventricular surgery. Generous resection at the surgical margin failed to control seizures and a VNS was placed, causing a moderate reduction in seizure frequency.
In six patients neocortical developmental abnormalities were visualized on preoperative MR images. In three patients widespread onset was documented by intracranial monitoring and the patients underwent palliative surgery consisting of placement of a VNS, corpus callosotomy, or subtotal resection. The first two patients eventually demonstrated a more focal cause for a majority of their seizures and eventually underwent a potentially curative sur- gical resection; in one patient a marked reduction in seizure frequency was achieved, and in the other patient no obvious improvement occurred. The patient who underwent subtotal resection had several types of seizure, the most severe of which localized to a focal region of neocortex. Although the patient's condition had not improved after the first surgery, no further resection was indicated and the patient ultimately underwent placement of a VNS, resulting in minimal improvement. Three other patients experienced more focal onsets, but had undergone subtotal resections of the anatomical abnormality to preserve adjacent functional cortex. In two of these patients, although the ictal onset zone was entirely removed, an adjacent area emerged as an independent focus. Additional neocortical resection involved the loss of some function (in this case visual fields). One patient achieved a marked reduction in seizure frequency, whereas the other experienced no improvement but achieved a marked reduction following placement of a VNS. In the third patient the majority of ictal onsets occurred in a single location, but failed to improve with focal resection; that patient underwent a corpus callosotomy, which led to only a moderate reduction in seizure frequency. Two patients with Rasmussen encephalitis and one patient with infantile hemiplegia underwent palliative subtotal resections, and in one case multiple subpial transections, to preserve functional cortex. The two patients with Rasmussen encephalitis continued to decline neurologically and, ultimately, underwent functional hemispherectomy. One of these patients is seizure free, whereas the other only achieved a moderate reduction in seizure frequency and electrographic abnormalities were documented in the contralateral hemisphere. The patient with infantile hemiplegia continues to have neurological function in the contralateral hand; that patient underwent placement of a VNS for additional seizure control and experienced a moderate reduction in seizure frequency.
Multifocal Onset
Two patients, in whom multifocal disease was clearly recorded on continuous video EEG of the scalp and whose structures appeared normal on MR images, had been treated with palliative corpus callosotomy. One patient later underwent placement of a VNS and achieved a marked reduction in seizure frequency. In the other patient a lateralized focus developed, which was resected with only a moderate reduction in seizure frequency.
Discussion
In this series of patients who underwent repeated operation for recurrent seizures after surgery for epilepsy, we found two distinct classes: patients in whom electrographic testing demonstrated that the onset zones were well localized and in whom the goal of surgery was curative, and patients whose diseases were severely intractable with multifocal onsets and in whom surgery was performed as a palliative procedure. In the former group, our data differ from those of earlier series in which authors reported a higher rate of cure (40-60%) following reoperation to remove adjacent neocortical or residual mesial structures. 1,19, 27,44,48,64 Because all patients in our series underwent preoperative MR imaging and because at YEC there is a low threshold for intracranial monitoring and a uniform approach to aggressive mesial resections, there were very few patients in whom residual lesional or epileptogenic tissue was either inadequately identified or incompletely resected. Hence, only four patients were actually rendered seizure free following the second operation: two patients with recurrent tumors, one patient in whom the hemispherectomy was completed, and one patient with dual pathology who had not undergone invasive monitoring and in whom the second surgery involved removal of unresected mesial structures. We are left to conclude that, if the first surgery is guided by concordance of noninvasive criteria or intracranial recording of ictal onsets and if all surgical objectives are adequately met, patients in whom treatment fails often experience the emergence of new epileptogenic areas, reflecting widespread disease that may not respond to additional surgery. Repeated surgery plays a major role only if one of the following conditions exist: residual epileptogenic structures are clearly identified, the initial electrographic monitoring was not adequately invasive, the cortex was not adequately sampled, progressive disease permits additional resection, or surgery is intended to be a palliative procedure.
Review of the Literature
Previously reported outcomes for all patients who underwent reoperation ranged from 20 to 63% of patients achieving freedom from seizures, with an additional 15 to 30% finding worthwhile improvement. 1, 19, 27, 44, 48, 64 Table 4 presents a summary of outcomes for all reoperations reported in the literature, depending on the site of the original resection and whether the reoperation was performed adjacent to the site of previous resection or in a more distant location. Patients who underwent repeated operations adjacent to a temporal lobe resection achieved the best outcomes, with 57% of patients free from seizure and 29% experiencing worthwhile improvement. Extratemporal resections performed at the margin of the prior resection also fared well, with 42% of patients free from seizure and 37% significantly improved. Patients in whom resections were distant from the site of the first surgery had poor outcomes, with only 19% seizure free and 12% significantly improved.
Our results differ from those of previous studies, predominantly because earlier reports included patients who had undergone either inadequate imaging, inadequate electrographic monitoring, or incomplete resections. Reoperation for failed epilepsy surgery was first mentioned by Pen- 64 reported on 37 patients of whom 48% became seizure free, with 26% achieving more than a 75% reduction in seizure frequency. Almost 30% of these patients, however, had undergone their first operation at another institution and their sites of epileptic activity were either inadequately localized or incompletely resected. Awad and colleagues 1 reported 15 reoperations performed at the Cleveland Clinic, of which 47% resulted in the patients being seizure free and 33% resulted in the patients experiencing more than a 90% reduction in seizure frequency. In most patients there were residual epileptogenic structures that had been inadequately resected or inadequately localized, and 33% of patients had undergone their first operations at another institution. Germano, et al., 19 reported on 40 patients with recurrent seizures who presented to the MNI after temporal lobe surgery. Sixty-three percent of patients were seizure free or experienced only rare seizures following reoperation. Almost 25% of these patients had undergone their first operation at another institution and almost 50% had no preoperative imaging. Residual hippocampal structures were found in all cases. The MNI experience with reoperation for extratemporal seizure foci was reported by Salanova, et al. 44 All thirty-nine patients in their series underwent the first operation at MNI guided by intraoperative electrocorticography. In an unidentified number of patients, pneumoencephalography or computerized tomography scanning was the only imaging procedure performed before the first resection. In these patients reoperation led to a seizure-free rate of 30%, with 31% of patients significantly improved. Results for repeated pediatric epilepsy surgery have been presented by Shaver, et al. 48 Twenty patients underwent reoperation, resulting in 55% of patients being seizure free and 15% being significantly improved. Although MR imaging had been performed in all patients prior to the first operation and invasive recordings had been obtained in many patients, 25% had undergone their first operation at another institution. Holmes, et al., 27 chronicled the cases of 21 patients who underwent both first and second surgeries at the University of Washington. All patients had undergone preoperative MR imaging and invasive monitoring when appropriate; after the second operation 43% were seizure free and 33% experienced significant improvements (Ͼ75% reduction in seizures). Of note, in a significant number of patients residual hippocampal structures were removed during the second operation.
The following is a summary of previously reported prognostic factors for outcome following repeated epilepsy surgery. 1, 19, 27, 44, 48, 64 Favorable outcomes occurred in the following patients: 1) those with residual structural lesions previously associated with epileptogenesis and concordant findings on repeated scalp EEG; and 2) those in whom reoperation extended the prior resection. Unfavorable outcomes occurred in the following cases: 1) patients in whom repeated electrographic monitoring demonstrated epileptogenesis distant from the original site of resection; 2) patients undergoing reoperation involving a site distant from the original surgery; 3) patients with multifocal abnormalities revealed by EEG; 4) patients with a history of encephalitis after age 4 years; and 5) patients who displayed recurrent seizures within 1 month postoperatively.
Curative Surgery
Mesial Temporal Sclerosis. In this series, the most common cause of treatment failure for epilepsy of mesial temporal origin that prompted an attempt at reoperation was dual pathology. Pathological specimens obtained in patients with MTS will have additional extrahippocampal disease identified in as many as 35%, particularly developmental abnormalities. 3, 31 Up to 50% may have volumetric structural abnormalities associated with developmental abnormalities that can be measured on MR images. 33, 51 The contribution of these additional lesions to epileptogenesis is not well understood, but may be a significant factor in the consistent 20 to 30% failure rate following medial resections. [31] [32] [33] 51 Conversely, isolated lesionectomy with sparing of an atrophic, epileptogenic hippocampus also results in a poor outcome. 10, 28, 32, 33 As many as 90% of patients with temporal lobe developmental abnormalities will have hippocampal atrophy, often bilaterally. 25, 29 Unfortunately, our results indicate that dual pathology, which do not respond to removal of the epileptogenic lesion, may indicate more widespread disease and may not respond to additional neocortical resection. The one patient with dual pathology who did respond to a second surgery had not undergone a Phase 3 evaluation, and an atrophic, epileptogenic hippocampus was not initially resected. Li, et al., 32 reported a series of patients with dual pathology in which removal of both the extratemporal disease and the sclerotic medial structures only resulted in a 73% seizure-free rate. The fact that systematic removal of both lesions does not significantly improve outcome statistics supports the hypothesis that many of these patients may have widespread disease.
Failure due to bitemporal disease was less common in this series. Bilateral asymmetric MTS has been demonstrated in autopsy studies in 10 to 50% of patients with limbic epilepsy. 3, 36 Independent bitemporal interictal spikes can be recorded from approximately 25% of patients on (28) 39 (28) 138 scalp EEG. 16 Unilateral medial resection in these patients often carries a decreased probability of good outcome, 6, 14, 34 although not in all series. 24 We can infer from these data that limbic epilepsy may be a bilateral disease with a broad spectrum of lateralization, although the possibility of secondary epileptogenesis cannot be ruled out. 20, 21, 37 Chronic bilateral intracranial monitoring can be used to identify patients with a higher probability of successful outcome following unilateral surgery, depending in some part on the degree of lateralization of the electrographic abnormalities in addition to structural and behavioral data. 11, 24, 26, 53 Nevertheless, secondary epileptogenesis may account for a certain percentage of failed surgeries and should be rigorously investigated in the initial evaluation and suspected in failed surgeries. Repeated resective surgery is not an option for these patients who may benefit from palliative surgery or further trials of medication.
Neocortical Surgery. The most common indications for repeated neocortical surgery were progressive tumors, developmental abnormalities, and hemispheric disease. For patients harboring tumors, recurrent seizures may arise from malignant degeneration, which has been reported in up to 50% of low-grade gliomas, or from regrowth of residual microscopic disease. 8, 18, 30 In the present series, reoperation was most successful at controlling seizures in patients with progressive tumors and also provided tissue for histological analysis, which was essential for determining further adjuvant therapy. Alternatively, stereotactic radiosurgery was used to treat neoplastic tissue residing in functional cortex, which may be less damaging than resective surgery, depending on the radiation dosage. 46 None of the patients with developmental abnormalities who underwent a second surgery became seizure free. These patients most likely had widespread disease that initially appeared electrographically and anatomically to be focal. Although new epileptogenic areas appeared to arise at the margin of the prior resection, there was no response to additional surgery. Several factors can contribute to mislocalization of neocortical developmental abnormalities. Even MR imaging may miss the extent of the lesion, which can sometimes only be detected using careful volumetric analysis. 50 Electrographic localization can also be misleading, even with intracranial monitoring. One inherent problem is sampling error. 35, 49 Although relatively safe, 58 there are clear risks associated with intracranial monitoring, which are a function of the number and invasiveness of the electrodes. Hence, concerns about safety and reduction of complications may contribute to inadequate sampling. 35 This may also be true for mesial onset epilepsy, in which the use of subdural rather than depth electrodes may not sample the site of initiation. 9 In addition, even when adequately covered, some epileptic foci do not produce localizing ictal or interictal events. This is particularly true for neocortical foci, regardless of whether an underlying lesion exists. 8 Although electrical data from lateral occipital and frontal foci may only localize the site of onset in less than 50% of patients, 2, 8, 43, 57 data from medial occipital or parietal foci may only localize the site in less than 15%. 8, 63 Hemispheric disease such as Rasmussen encephalitis or infantile hemiplegia may require hemispherectomy for seizure control, but the operations must sometimes be subtotal to preserve functional cortex. 41, 60 Disease progression may eliminate function, and reoperation for completion of the hemispherectomy can then be performed. Even following complete functional hemispherectomy, however, up to 33% of patients will experience persistent seizures. 52, 60, 61 These may arise from residual tissue or progressive involvement of the contralateral hemisphere. 52, 61 Postsurgical injury may also have played a role in the induction of recurrent epileptogenesis. 22 Evidence in favor of this form of iatrogenic epilepsy includes the high incidence of epilepsy following surgical isolation of normal cortex in the laboratory. 15 Indeed, all epilepsy associated with structural lesions may be related to cortical injury. 22 Reoperation for failed epilepsy surgery demonstrates a high incidence of epileptogenesis adjacent to the surgical margin. 1, 64 The fact that new postresection injury spikes do not appear to correlate with the occurrence of seizures, in addition to the high cure rate after epilepsy surgery, make iatrogenic epileptogenesis unlikely. 47 A genetic predisposition toward epileptogenesis may play an important role in this phenomenon. 7 
Palliative Surgery
Patients with severely intractable nonlocalizing epilepsy may be candidates for palliative surgery. Corpus callosotomy was the most common alternative, particularly for patients with atonic seizures that carry a demonstrated risk of personal injury. 45, 56 The neuropsychological sequelae of callosal division can be quite detrimental to some patients, as can the exacerbation of severe partial seizures. 45 The VNS was approved by the United States Food and Drug Administration in 1997 for use as an adjunctive treatment in adults and adolescents with medically refractory partial onset seizures. 5, 23, 59 Recent studies have demonstrated that indications for VNS placement are increasing and include use in children as well as for certain primarily generalized epilepsies. 4, 39 Long-term results appear to be promising. 13, 38 We have found the VNS to be a helpful adjunct in treating patients in whom an initial surgical intervention has failed. Indications for VNS placement include both patients who have previously undergone corpus callosotomy for multifocal epilepsy and patients who display recurrent intractable seizures after resective surgery whose workup fails to reveal an identifiable focus amenable to further resection. Although palliative surgery reduced seizure frequency in a majority of patients in this study, the impact of persistent seizures on quality of life measures was not examined. The overall benefit of palliative repeated epilepsy surgery is unclear.
Conclusions
The purpose of this study was to characterize the indications and outcomes for patients undergoing a second operation for epilepsy in a center where all patients underwent preoperative MR imaging, invasive monitoring, and aggressive medial temporal resection when indicated. We found that patients who appear anatomically and electrographically to have localized onsets and in whom adequate resective surgery has failed have a much lower chance of becoming seizure free after a second surgery than previously reported in the literature. The only successful reoperative interventions were found in patients with recurrent tumors, incomplete functional hemispherectomy, or inadequate invasive monitoring. We conclude that in patients who have received an adequate preoperative evaluation and surgical intervention, unless there is compelling evidence that reoperation will be successful, a second surgery should be considered a palliative procedure. The role of the VNS in this situation is still developing, but may provide a reasonable alternative for patients in whom a first operation has failed.
